SimBioSys names Stacey Stevens as new President and CEO
January 2025- SimBioSys announced the appointment of AI-driven medical device executive Stacey Stevens as its President and Chief Executive Officer. SimBioSysโ... Read more.
Americares Launches Response to California Wildfires
January 2025- As wildfires ravage Los Angeles, Americares has initiated a rapid response to restore health services and address urgent medical needs in affected... Read more.
Pulse Biosciences appoints Paul LaViolette as new Chief Executive Officer
January 2025- Pulse Biosciences, inc. announced the appointment of Paul A. LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. “We are... Read more.
Gaza Hospitals Face Closure Due to Fuel Shortages, Warns MSF
January 2025- Hospitals in Gaza, including Nasser Hospital, Al-Aqsa Hospital, and the European Gaza Hospital, are on the brink of closure due to severe fuel shortages,... Read more.
Ardent Health acquires 18 urgent care clinics across new Mexico and Oklahoma
January 2025- Ardent Health announced it has acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care. โExpanding our urgent care... Read more.
Axios International showcases global and regional success stories at DUPHAT 2025
Dubai, UAE- January 2025- Axios International highlighted its global and regional success stories that have made access to healthcare a reality for millions of patients... Read more.
First in Middle East: ADSCC Develops Virus-Free, Clinical-Grade Induced Pluripotent Stem Cells
Abu Dhabi, UAE- January 2025-The Abu Dhabi Stem Cells Center (ADSCC) has successfully developed clinical-grade induced pluripotent stem cells (iPSCs) that comply... Read more.
DUPHAT 2025 Starts Tomorrow, Highlighting Pharma Innovations in Dubai
Dubai, UAE- 06 January- Dubai is set to host the 30th edition of Dubai International Pharmaceuticals and Technologies Conference and Exhibition – DUPHAT, which... Read more.
GSK announces FIRST trial met its primary endpoint of progression free survival in ovarian cancer
GSK plc (LSE/NYSE: GSK) announced headline results from the FIRST-ENGOT-OV44 phase III trial evaluatingย Zejulaย (niraparib) andย Jemperliย (dostarlimab) in first... Read more.
Anthem Blue Cross and Blue Shield Parent Company Completes Indiana University Health Plans Acquisition
INDIANAPOLIS โ Anthem Blue Cross and Blue Shield parent company announced today the closing of its acquisition of Indiana University Health Plans (โIU Health... Read more.
